{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:08:36Z","timestamp":1790366916880,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.4158\/ep12400.cr","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T21:18:33Z","timestamp":1372799913000},"page":"e145-e149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Role of Temozolomide in the Treatment of a Patient With a Pure Silent Pituitary Somatotroph Carcinoma"],"prefix":"10.1016","volume":"19","author":[{"given":"Leonardo Vieira","family":"Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Chimelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Jos\u00e9 da M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson L.","family":"Gasparetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Bines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Eduardo A.","family":"Wildemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica R.","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP12400.CR_bb0010","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2011-1166","article-title":"Pituitary carcinoma with malignant growth from first presentation and fulminant clinical course\u2014 case report and review of the literature","volume":"96","author":"Dudziak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12400.CR_bb0015","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1210\/jc.2004-2231","article-title":"Clinical review: diagnosis and management of pituitary carcinomas","volume":"90","author":"Kaltsas","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12400.CR_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/ENDO:28:1:115","article-title":"Pituitary carcinoma: diagnosis and treatment","volume":"28","author":"Lopes","year":"2005","journal-title":"Endocrine"},{"key":"10.4158\/EP12400.CR_bb0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1227\/00006123-198806010-00023","article-title":"Malignant growth hormone-secreting pituitary adenoma with hematogenous dural metastasis: case report","volume":"22","author":"Asai","year":"1988","journal-title":"Neurosurgery"},{"key":"10.4158\/EP12400.CR_bb0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1365-2265.1996.685507.x","article-title":"Biochemical cure of recurrent acromegaly by resection of cervical spinal canal metastases","volume":"44","author":"Dayan","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP12400.CR_bb0035","first-page":"1628","article-title":"Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone-secreting metastasis detected by 111-indium pentetreotide scan","volume":"81","author":"Greenman","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12400.CR_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3171\/jns.1986.64.1.0140","article-title":"Intracranial and intraspinal dissemination from a growth hormone-secreting pituitary tumor. Case report","volume":"64","author":"Hashimoto","year":"1986","journal-title":"J Neurosurg"},{"key":"10.4158\/EP12400.CR_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/02688699409002399","article-title":"Cervical lymph nodes metastases from a pituitary carcinoma","volume":"8","author":"Jamjoom","year":"1994","journal-title":"Br J Neurosurg"},{"key":"10.4158\/EP12400.CR_bb0050","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM200111293452216","article-title":"Pituitary carcinoma as a cause of acromegaly","volume":"345","author":"le Roux","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12400.CR_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000441-198908000-00007","article-title":"Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma","volume":"298","author":"Mountcastle","year":"1989","journal-title":"Am J Med Sci"},{"key":"10.4158\/EP12400.CR_bb0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/019131201300343865","article-title":"Pituitary carcinoma: an ultrastructural study of eleven cases","volume":"25","author":"Scheithauer","year":"2001","journal-title":"Ultrastruct Pathol"},{"key":"10.4158\/EP12400.CR_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.1992.tb02306.x","article-title":"Growth hormone secreting pituitary carcinoma: a case report and literature review","volume":"37","author":"Stewart","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP12400.CR_bb0070","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7326\/0003-4819-117-12-1057","article-title":"Acromegaly and pituitary carcinoma","volume":"117","author":"Yamashita","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP12400.CR_bb0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2265.2001.01322.x","article-title":"Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma","volume":"55","author":"Zahedi","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP12400.CR_bb0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11102-011-0363-7","article-title":"Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature","volume":"15","author":"Annamalai","year":"2012","journal-title":"Pituitary"},{"key":"10.4158\/EP12400.CR_bb0085","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2265.2012.04381.x","article-title":"Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment","volume":"76","author":"Raverot","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP12400.CR_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53","volume":"94","author":"Kasuki Jomori de Pinho","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.4158\/EP12400.CR_bb0095","series-title":"World Health Organization Classification of tumours Pathology and Genetics of Tumors of Endocrine Organs","first-page":"3","article-title":"Pituitary tumours: introduction","author":"Lloyd","year":"2004"},{"key":"10.4158\/EP12400.CR_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006123-199601000-00024","article-title":"Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody","volume":"38","author":"Thapar","year":"1996","journal-title":"Neurosurgery"},{"key":"10.4158\/EP12400.CR_bb0105","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/07357907.2010.512598","article-title":"Anticancer properties of zoledronic acid","volume":"28","author":"Green","year":"2010","journal-title":"Cancer Invest"},{"key":"10.4158\/EP12400.CR_bb0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1470-2045(06)70728-8","article-title":"Temozolomide: a novel treatment for pituitary carcinoma","volume":"7","author":"Lim","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.4158\/EP12400.CR_bb0115","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1210\/jc.2010-0441","article-title":"Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression","volume":"95","author":"Bush","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12400.CR_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-09-0389","article-title":"Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy","volume":"161","author":"Hagen","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP12400.CR_bb0125","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12400.CR_bb0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11102-010-0249-0","article-title":"MGMT immunoexpression in aggressive pituitary adenoma and carcinoma","volume":"13","author":"Lau","year":"2010","journal-title":"Pituitary"},{"key":"10.4158\/EP12400.CR_bb0135","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2362.2011.02520.x","article-title":"Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status","volume":"41","author":"McCormack","year":"2011","journal-title":"Eur J Clin Invest"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20431131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20431131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/F102056126J46338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:56:44Z","timestamp":1761515804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20431131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1530891X20431131"],"URL":"https:\/\/doi.org\/10.4158\/ep12400.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Temozolomide in the Treatment of a Patient With a Pure Silent Pituitary Somatotroph Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12400.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}